Acutaas Chemicals share price
Acutaas Chemicals Ltd. · NSE: ACUTAAS · Healthcare
Price, one year
Price range
- Open
- ₹3,219.40
- High
- ₹3,236.70
- Low
- ₹3,085.00
- Previous close
- ₹3,215.30
- Volume
- 3.5 L
- Market cap
- ₹25,689 Cr
Key statistics
Results to 30 Jun 2026 · Consolidated- P/E (TTM)
- 66.5
- Price to book
- 15.5
- Return on equity
- 23.4%
- EPS (TTM)
- ₹47.17
- Book value / share
- ₹201.97
- Debt to equity
- 0.02
- Revenue (TTM)
- ₹1,462 Cr
- Net profit (TTM)
- ₹386 Cr
- Sales growth, YoY
- +59.1%
- Profit growth, YoY
- +67.7%
- Operating margin
- 37.1%
- Net margin
- 26.4%
- Sales CAGR, 3 years
- +29.5%
- Profit CAGR, 3 years
- +62.3%
- Promoter holding
- 32.66%
- Promoter shares pledged
- 0.00%
Shareholding pattern
% of shares| Holder | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|
| Promoters | 32.66 | 32.66 | 32.66 |
| Foreign institutions | 19.48 | 21.61 | 22.62 |
| Domestic institutions | 19.60 | 19.56 | 19.40 |
| Mutual funds | 13.86 | 14.17 | 14.44 |
| Retail and others | 23.21 | 21.72 | 21.15 |
Results and announcements
Latest results (quarter to 30 Jun 2026) filed 24 Jul 2026. results: 27 Oct 2026.
- 17 Oct 2026 · DealAcquisitionAcutaas Chemicals Limited has informed the Exchange about Acquisition
Peers in Healthcare
All Healthcare stocks| Company | Price | Change |
|---|---|---|
| Sun Pharmaceutical IndustriesSUNPHARMA | ₹1,748.00 | −0.57% |
| Divi's LaboratoriesDIVISLAB | ₹8,950.00 | −2.31% |
| Torrent PharmaceuticalsTORNTPHARM | ₹4,524.40 | −1.97% |
| Zydus LifesciencesZYDUSLIFE | ₹1,129.40 | −0.49% |
| Apollo Hospitals EnterpriseAPOLLOHOSP | ₹7,730.00 | +1.65% |
| CiplaCIPLA | ₹1,338.00 | +0.53% |
| Laurus LabsLAURUSLABS | ₹1,970.00 | −1.62% |
| Dr. Reddy's LaboratoriesDRREDDY | ₹1,229.50 | −0.77% |
| Mankind PharmaMANKIND | ₹2,212.60 | −2.77% |
| Aurobindo PharmaAUROPHARMA | ₹1,571.70 | −2.43% |
Frequently asked questions
What is the share price of Acutaas Chemicals today?
Acutaas Chemicals (NSE: ACUTAAS) was at ₹3,137.70 on 23 Oct 2026, a change of −2.41% from the previous close.
What are the 52-week high and low of Acutaas Chemicals?
Over the last 52 weeks Acutaas Chemicals traded between ₹1,470.00 and ₹3,740.00 (daily highs and lows on NSE on 23 Oct 2026).
What is the market capitalisation of Acutaas Chemicals?
About ₹25,689 Cr at the latest price, with a P/E of 66.5, a price-to-book of 15.5, a return on equity of 23.4%. Ratios use the company's latest reported results.
Who owns Acutaas Chemicals shares?
According to the shareholding pattern filed with the exchange at the end of the quarter to 30 Sep 2026, promoters held 32.66%, foreign institutions 22.62%, domestic institutions 19.40%.
Which sector and indices does Acutaas Chemicals belong to?
NSE classifies Acutaas Chemicals under Healthcare; it is a member of Nifty 500.
Follow Acutaas Chemicals with research you can verify. Add it to a watchlist, see screens and charts, and get calls from SEBI-registered research analysts with recorded track records.
Start free trial